NFE2L2 and major depressive disorder: The implication of NRF2 and SOD2 in altered leukocyte transcription in MDD subjects suggests a potential leukocyte gene transcriptional biomarker in MDD, a potential target for therapeutic intervention, and a potential biomarker of effective treatment.